Syndax Pharmaceuticals
(NASDAQ) SNDX
Syndax Pharmaceuticals Financials at a Glance
Market Cap
$1.75B
Revenue (TTM)
$217.17M
Net Income (TTM)
$243.25M
EPS (TTM)
$-2.80
P/E Ratio
-7.07
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Price
$19.96
Volume
25,833
Open
$19.84
Price
$19.96
Volume
25,833
Open
$19.84
Previous Close
$19.77
Daily Range
$19.84 - $20.55
52-Week Range
$8.59 - $25.59
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Price
$19.96
Volume
25,833
Open
$19.84
Previous Close
$19.77
Daily Range
$19.84 - $20.55
52-Week Range
$8.59 - $25.59
SNDX News
SNDX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Syndax Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
298
CEO
Michael A. Metzger, MBA
Website
www.syndax.comHeadquarters
New York City, MA 02451, US
SNDX Financials
Key Financial Metrics (TTM)
Gross Margin
98%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
-190%
Return on Capital
-58%
Return on Assets
-51%
Earnings Yield
-14.14%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.75B
Shares Outstanding
88.61M
Volume
25.83K
Avg. Volume
1.57M
Financials (TTM)
Gross Profit
$165.38M
Operating Income
$273.08M
EBITDA
$251.63M
Operating Cash Flow
$322.98M
Capital Expenditure
$187.00K
Free Cash Flow
$323.17M
Cash & ST Invst.
$394.07M
Total Debt
$346.48M
Syndax Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$64.86M
+223.6%
Gross Profit
$62.23M
+224.8%
Gross Margin
95.94%
N/A
Market Cap
$1.75B
N/A
Market Cap/Employee
$6.49M
N/A
Employees
270
N/A
Net Income
$42.67M
+49.7%
EBITDA
$30.82M
+63.2%
Quarterly Fundamentals
Net Cash
$6.70M
-98.7%
Accounts Receivable
$38.12M
+77.4%
Inventory
$34.95M
+649.3%
Long Term Debt
$344.87M
+23635.2%
Short Term Debt
$488.00K
+27.1%
Return on Assets
-51.46%
N/A
Return on Invested Capital
-57.84%
N/A
Free Cash Flow
$50.34M
+47.1%
Operating Cash Flow
$50.34M
+47.1%